After a 35-year career in the finance industry, including two decades as an institutional stockbroker at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on div
Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive
Brentview Investment Management LLC lessened its position in shares of Johnson and Johnson (NYSE: JNJ) by 2.0% in the second quarter, according to the company in its most recent 13F filing with the Se
Boston Family Office LLC lessened its stake in Johnson and Johnson (NYSE: JNJ) by 9.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
Intuitive Surgical shows why now is a good time to consider buying surgical-robot competitor Medtronic. Eli Lilly helps explain why down-and-out drugmaker Pfizer could be worth a close look for long-t

2 Top Dividend Stocks to Buy and Hold

04:05am, Sunday, 30'th Nov 2025
Bristol Myers Squibb and Johnson & Johnson have had a tough past few years due to several factors. Both companies are looking to right the ship thanks to new product launches.
Berry Wealth Group LP lessened its holdings in Johnson and Johnson (NYSE: JNJ) by 1.4% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 18,336 shares of the c
Through the end of November, the year-to-date total return of the Dogs of the Dow equals 20.96%, outpacing the Dow Jones Industrial Average return of 13.86% and outpacing the broader S&P 500 Index ret
JNJ's oncology sales surge on strong drug launches and pipeline momentum, raising the stakes for its ambitious $50B 2030 goal.
The Wasatch Global Value Fund - Investor Class gained 6.36% in the third quarter of 2025, outperforming the MSCI All Country World Value Index, which added 6.13%. Leading contributors to the Fund's pe
Johnson & Johnson is a financial fortress with a solid pipeline and portfolio. Coca-Cola has an asset-light model that drives its profitability.
Pfizer and Johnson & Johnson are healthcare leaders and faithful dividend payers. Home Depot is facing a difficult operating environment, but its core business remains strong.
Representative Lisa C. McClain (R-Michigan) recently sold shares of Johnson and Johnson (NYSE: JNJ). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Guru Stock PicksJefferies Group has made the following transactions:Reduce in CLDX by 12.28%Sold out in UNFIAdd in SMH by 25.28%New position in XNCRT Rowe Price
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE